某些与胰岛素抵抗/高胰岛素血症/内脏肥胖相关的亚临床异常组合可能预示着严重的ASCVD风险残余,这是经典风险计算器,包括血管性痴呆/美国心脏协会血管性痴呆风险计算器(ACC/AHA ASCVD risk calculator)、弗雷明翰冠心病风险评分(the Framingha...
某些与胰岛素抵抗/高胰岛素血症/内脏肥胖相关的亚临床异常组合可能预示着严重的ASCVD风险残余,这是经典风险计算器,包括血管性痴呆/美国心脏协会血管性痴呆风险计算器(ACC/AHA ASCVD risk calculator)、弗雷明翰冠心病风险评分(the Framingham CHD risk score)、英国前瞻性糖尿病研究风险引擎(the United Kingdom Prospective...
Compared with anon-HDLless than 2.6 mmol/L, there was an increase in CVD with non-HDL between 2.6 mmol/L and less than 3.7 mmol/L (HR = 1.1; 95% CI, 1-1.3) and for levels of 5.7 mmol/L and greater (HR = 1.9; 95% CI, 1.6-2.2) for women. This association was also se...
某些与胰岛素抵抗/高胰岛素血症/内脏肥胖相关的亚临床异常组合可能预示着严重的ASCVD风险残余,这是经典风险计算器,包括血管性痴呆/美国心脏协会血管性痴呆风险计算器(ACC/AHA ASCVD risk calculator)、弗雷明翰冠心病风险评分(the Framingham CHD risk score)、英国前瞻性糖尿病研究风险引擎(the United Kingdom Prospective...